Kate Haviland insider trades

Open-market stock purchases and sales by Kate Haviland, Unknown at Fulcrum Therapeutics, Inc, from SEC Form 4 filings since Feb 1, 2016.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +194%.

Recent trades

DateStockTradeValue
Jun 30, 2026FULC Fulcrum Therapeutics, IncBought (not open market)—
Jun 9, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Apr 29, 2026AVLN Avalyn Pharma IncBought (not open market)—

Companies traded

  • FULC Fulcrum Therapeutics, Inc: other filings, last Jun 30, 2026
  • BCAX Bicara Therapeutics Inc: other filings, last Jun 9, 2026
  • AVLN Avalyn Pharma Inc: other filings, last Apr 29, 2026
  • BPMC Blueprint Medicines Corp: 1 buy, 73 sales, last Jul 17, 2025

Get free alerts when Kate Haviland files a new trade →